The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies.

Sophie BoweBirgitte Mitlid-MorkAntoniya GeorgievaJon M GranChristopher W G RedmanAnne Cathrine StaffMeryam Sugulle

Published in: Acta obstetricia et gynecologica Scandinavica (2021)

In clinically healthy post-date pregnancies, an antiangiogenic pre-delivery profile (lower PlGF level and higher sFlt-1/PlGF ratio) was associated with composite adverse delivery outcome of a likely placental cause.

Keyphrases

preterm birth
pregnancy outcomes
emergency department
pregnant women
adverse drug